Zobrazeno 1 - 10
of 34
pro vyhledávání: '"ELENA YOUNOSSI"'
Autor:
Zobair M. Younossi, Maria Stepanova, Brian Lam, Rebecca Cable, Sean Felix, Thomas Jeffers, Elena Younossi, Huong Pham, Manirath Srishord, Patrick Austin, Michael Estep, Kathy Terra, Carey Escheik, Leyla deAvila, Pegah Golabi, Andrej Kolacevski, Andrei Racila, Linda Henry, Lynn Gerber
Publikováno v:
Hepatology Communications, Vol 6, Iss 11, Pp 3062-3072 (2022)
The impact of the coronavirus disease 2019 (COVID‐19) pandemic among patients with chronic liver disease is unknown. Given the high prevalence of nonalcoholic fatty liver disease (NAFLD), we determined the predictors of mortality and hospital resou
Externí odkaz:
https://doaj.org/article/6dc06c8e1ef64e35b359559ab68fca45
Autor:
Zobair M. Younossi, Yusuf Yilmaz, Mohamed El‐Kassas, Ajay Duseja, Saeed Hamid, Gamal Esmat, Nahum Méndez‐Sánchez, Wah Kheong Chan, Ashwani K. Singal, Brian Lam, Sean Felix, Elena Younossi, Manisha Verma, Jillian K. Price, Fatema Nader, Issah Younossi, Andrei Racila, Maria Stepanova
Publikováno v:
Hepatology Communications, Vol 6, Iss 10, Pp 2860-2866 (2022)
Abstract Patients with preexisting chronic liver disease (CLD) may experience a substantial burden from both coronavirus 2019 (COVID‐19) infection and pandemic‐related life disruption. We assessed the impact of the COVID‐19 pandemic on patients
Externí odkaz:
https://doaj.org/article/84014429ef074574bdf4a6a0d13c9f95
Autor:
Maria Stepanova, Brian Lam, Elena Younossi, Sean Felix, Mariam Ziayee, Jillian Price, Huong Pham, Leyla de Avila, Kathy Terra, Patrick Austin, Thomas Jeffers, Carey Escheik, Pegah Golabi, Rebecca Cable, Manirath Srishord, Chapy Venkatesan, Linda Henry, Lynn Gerber, Zobair M. Younossi
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background COVID-19 outcomes among hospitalized patients may have changed due to new variants, therapies and vaccine availability. We assessed outcomes of adults hospitalized with COVID-19 from March 2020–February 2022. Methods Data were r
Externí odkaz:
https://doaj.org/article/c669c9b3af3e4a2286a0e2e024489b41
Autor:
James M. Paik, Linda Henry, Leyla De Avila, Elena Younossi, Andrei Racila, Zobair M. Younossi
Publikováno v:
Hepatology Communications, Vol 3, Iss 11, Pp 1459-1471 (2019)
Population‐level nonalcoholic fatty liver disease (NAFLD) death rate data are sparse. We described death rates for adults with NAFLD in the United States using mortality data from the National Vital Statistics System multiple‐cause mortality data
Externí odkaz:
https://doaj.org/article/d3911e45bfb34ec2bfae99763b26004b
Autor:
Zobair M. Younossi, Maria Stepanova, Sean Felix, Thomas Jeffers, Elena Younossi, Zachary Goodman, Andrei Racila, Brian P. Lam, Linda Henry
Publikováno v:
Alimentary Pharmacology & Therapeutics. 57:1417-1422
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a4b5a297c74842b9411b217545d076df
https://doi.org/10.1111/apt.17472
https://doi.org/10.1111/apt.17472
Autor:
Leyla de Avila, Jillian K. Price, Maria Stepanova, Brian Lam, Ali A. Weinstein, Huong Pham, Patrick Austin, Wisna Keo, Zaid Younossi, Mariam Afendy, Samir Nader, Kathy Terra, Rebecca Cable, Elena Younossi, Pegah Golabi, Manisha Verma, Fatema Nader, Andrei Racila, Lynn H. Gerber, Zobair M. Younossi
Publikováno v:
American Journal of Physical Medicine & Rehabilitation. 102:433-443
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::420684c2967dc7d3b4e74870a6a2c7cd
https://doi.org/10.1097/phm.0000000000002197
https://doi.org/10.1097/phm.0000000000002197
Autor:
ZOBAIR YOUNOSSI, SEAN FELIX, THOMAS JEFFERS, ELENA YOUNOSSI, FATEMA NADER, ANDREI RACILA, BRIAN P. LAM, MARIA STEPANOVA
Publikováno v:
Diabetes. 71
Background: Patients with nonalcoholic fatty liver disease (NAFLD) and fibrosis stage ≥ 2 (F2-F4) are at risk for adverse outcomes and considered to be candidates for clinical trials. We aimed to use two NITs combined to rule in and rule out fibros
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f2f4b678cde2829f92662f8322649b3c
https://doi.org/10.2337/db22-1121-p
https://doi.org/10.2337/db22-1121-p
Autor:
Pegah Golabi, James M. Paik, Michael Harring, Elena Younossi, Khaled Kabbara, Zobair M. Younossi
Publikováno v:
Clinical Gastroenterology and Hepatology. 20:2838-2847.e7
Nonalcoholic fatty liver disease (NAFLD) subjects with fibrosis stage ≥2 are at high risk for mortality. We aimed to provide national estimates and temporal trends for NAFLD, based on different fibrosis severity.Data from the National Health and Nu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8f333246183201d4583d46834c9777f
https://doi.org/10.1016/j.cgh.2021.12.015
https://doi.org/10.1016/j.cgh.2021.12.015
Autor:
Huong Pham, Brian Lam, Pegah Golabi, Linda Henry, Zobair M. Younossi, Andrei Racila, Sean Felix, Kathy L. Terra, Maria Stepanova, Manirath K. Srishord, Elena Younossi, Lynn H. Gerber, Michael Estep, Leyla de Avila, Patrick Austin, Andrej Kolacevski, Carey Escheik, Thomas Jeffers, Rebecca Cable
Publikováno v:
Hepatology Communications
The impact of the coronavirus disease 2019 (COVID‐19) pandemic among patients with chronic liver disease is unknown. Given the high prevalence of nonalcoholic fatty liver disease (NAFLD), we determined the predictors of mortality and hospital resou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cfa3d99829d0975cd956c3acefa78bf
http://europepmc.org/articles/PMC8426701
http://europepmc.org/articles/PMC8426701
Publikováno v:
Hepatology Communications, Vol 3, Iss 11, Pp 1459-1471 (2019)
Hepatology Communications
Hepatology Communications
Population‐level nonalcoholic fatty liver disease (NAFLD) death rate data are sparse. We described death rates for adults with NAFLD in the United States using mortality data from the National Vital Statistics System multiple‐cause mortality data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bc4e20b726e50417e4dc1abf82c925d
https://doi.org/10.1002/hep4.1419
https://doi.org/10.1002/hep4.1419